Venture Partner at Hadean Ventures
Check size: Hadean Ventures does not publish a standard current check-size range on its official website.
Reinhard Krickl invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.
Explain the science, unmet need, evidence, regulatory and clinical plan, intellectual-property position and the value-inflection milestone.
Strong science, clear clinical need, defensible intellectual property and teams able to translate research into valuable healthcare products.
Companies outside life science and healthcare, or without credible scientific and clinical foundations, are outside the stated focus.